Lorazepam: Why It Works and Why It Is Short-Term

Orfidal is one of several brand names for lorazepam, a benzodiazepine. It is among the most effective drugs in medicine for what it does: severe anxiety subsides within an hour, reliably, in almost everyone who takes it.

That effectiveness is the whole problem. A medicine that works that well, that quickly, for something that distressing, is one people want to keep taking — and it is not a medicine that can be kept taking.

⚡ How it works

The brain has a main calming signal, and lorazepam amplifies it.

That signal acts on receptors that let charged particles into nerve cells, making them harder to fire. Lorazepam binds at a separate site on the same receptor and increases how often those channels open when the natural signal arrives. It does not create calm from nothing; it turns up a control that already exists.

That mechanism explains both the effect and the problem. Amplification of the main inhibitory system produces reduced anxiety, muscle relaxation, sedation, anticonvulsant effect and memory impairment together, because all of them run through the same system. And sustained amplification causes the system to adapt by reducing its own sensitivity, which is tolerance.

Lorazepam sits in the middle of the benzodiazepine range for duration, taking effect within an hour and lasting most of a day. Unlike some others it is broken down without producing active by-products, which is why it is often preferred where liver function is reduced or in older people.

✅ Where it genuinely belongs

The list is shorter than the number of prescriptions written would suggest, and on it the drug is excellent.

• Severe acute anxiety or a crisis, for days rather than months, while something else is put in place
• Alcohol withdrawal, where benzodiazepines are first-line and genuinely prevent seizures and death
• Prolonged seizures, as emergency treatment
• Before procedures, where sedation and the amnesia it causes are both intended
• Anticipatory nausea with chemotherapy
• Catatonia, where it can produce a striking response

What it is not for is the ongoing management of anxiety, insomnia or stress, which is what most long-term prescriptions end up being.

📉 Dependence, stated plainly

Two different things are often confused here, and separating them removes a lot of unnecessary shame.

Physical dependence means the body has adapted, so stopping produces withdrawal. It develops in anyone taking the drug regularly for long enough, regardless of how carefully or how honestly they took it. It is a pharmacological fact, not a character failing, and it happens to people taking exactly what they were prescribed.

Addiction means compulsive use despite harm, escalating doses, obtaining supplies elsewhere. That is a different situation and a much less common one.

The great majority of people who find themselves unable to stop are in the first category. Being told they are addicted, when they have taken precisely what was prescribed for months because nobody reviewed it, is both inaccurate and unhelpful.

🚫 The combination that kills

Benzodiazepines are safe in overdose on their own to a degree that is unusual among sedatives. That safety disappears in combination.

With opioids — prescribed painkillers, codeine, tramadol, morphine, or anything illicit — the two suppress breathing through different routes and the effect multiplies rather than adds. This combination carries a formal boxed warning in multiple countries and accounts for a large share of overdose deaths involving either drug.

With alcohol, the same problem. Alcohol acts on the same receptor system, and the combination produces sedation and respiratory depression far beyond what either would cause alone, along with blackouts and behaviour the person has no memory of.

With other sedatives — sleeping tablets, sedating antihistamines, some antipsychotics — the same principle applies at lower intensity.

Anyone taking lorazepam should tell every prescriber, and should not accept an opioid painkiller without that conversation happening explicitly.

🧓 Older adults

Benzodiazepines appear on formal lists of medicines to avoid in older people, for reasons that are concrete rather than theoretical.

Falls and fractures. Sedation, unsteadiness and slowed reactions in someone whose balance is already less reliable. A hip fracture is a life-changing event and benzodiazepines measurably increase the risk.

Confusion. They impair memory and attention, and in someone with early cognitive difficulty they can look exactly like worsening dementia — which then gets attributed to the illness rather than the tablet.

Slower clearance. Older bodies clear the drug less quickly, so the same dose produces higher levels and longer effects.

There is also an observed association between long-term benzodiazepine use and later dementia. Whether the drug contributes or whether early cognitive change leads to the prescribing is genuinely unresolved, and the association is a further reason for caution rather than a proven cause.

🚗 Driving, memory and behaviour

Driving. Impairment is substantial and often unrecognised, since the drug reduces the awareness of being impaired along with everything else. Many jurisdictions treat driving on benzodiazepines the way they treat alcohol. The first days of treatment and any dose increase are the highest-risk periods.

Memory. Difficulty forming new memories while the drug is active is a normal effect, not a malfunction. It is why the drug is used before procedures, and it is a genuine nuisance otherwise — conversations, instructions and events can simply not be recorded.

Paradoxical reactions. In a minority, benzodiazepines produce the opposite of what is intended: agitation, restlessness, irritability, disinhibition and occasionally aggression. It is commoner in children, in older adults, and in some personality types. Anyone who becomes more agitated after taking it should stop and report it rather than concluding a higher dose is needed.

🔄 What else there is

The reason to be strict about duration is that better long-term options exist for anxiety.

Buspirone is the non-benzodiazepine anxiolytic. It acts on serotonin rather than the calming system above, so it causes no dependence, no tolerance, no withdrawal and very little sedation, and it can be taken indefinitely. Its limits are equally clear: it takes two to four weeks to work, it must be taken every day, and it does nothing taken in the moment of a panic attack. It also tends to work less well in people who have previously taken benzodiazepines, who find its effect subtle by comparison.

Antidepressants of the SSRI and SNRI groups are first-line for generalised anxiety, panic and social anxiety, and are what most long-term treatment should be.

Cognitive behavioural therapy matches medication for effectiveness in anxiety disorders and, unlike medication, its benefit persists after treatment ends. The article on generalised anxiety disorder covers how these are chosen between.

🪜 Coming off it

This is done slowly and it is entirely achievable. The principles matter more than any particular schedule.

Reduce gradually. Typical reductions are small — often around a tenth of the current dose — every two to four weeks, and slower where needed. Someone who has taken it for years may take a year to come off, and that is a success rather than a failure.

Consider switching to a longer-acting benzodiazepine first. Because lorazepam clears relatively quickly, levels dip between doses and each reduction is felt sharply. Switching to an equivalent dose of a longer-acting drug smooths that and makes the taper considerably more tolerable.

Expect symptoms to fluctuate. Withdrawal comes in waves rather than declining steadily, and a bad week after several good ones is normal and not evidence the taper has failed.

Hold rather than reverse when a reduction proves difficult. Staying at the current dose for longer is the usual answer, not going back up.

Do not let anyone rush it. Tapers imposed faster than the person can tolerate are the commonest reason attempts fail, and a failed attempt makes the next one harder.

Have something else in place — treatment for the underlying anxiety, and ideally psychological support — before removing what has been managing it.

🩺 When to seek help

• Severe difficulty breathing or extreme drowsiness, particularly with alcohol or an opioid — emergency
• A seizure, particularly after missing doses or stopping
• Having run out after regular use — same day, rather than waiting
• Becoming more agitated or aggressive after taking it
• Falls, unsteadiness or new confusion, particularly in an older person
• Still taking it beyond four weeks without a review
• Needing more than before for the same effect
• Being offered an opioid painkiller while taking it
• Pregnancy or planning it, since benzodiazepines are avoided
• Thoughts of self-harm — immediately

Benzodiazepines are controlled substances and are not stocked here. Lorazepam requires a local prescriber and a local pharmacy, and short courses are the only appropriate use. The non-benzodiazepine option is available in the anti-anxiety category as Buspar (buspirone), and antidepressant treatment for anxiety in the antidepressant category. Neither works in the moment, and both are what long-term treatment should look like.

❓ Frequently asked questions

📑 Sources and editorial

• Prescribing information for lorazepam, including the boxed warning on concomitant opioid use
• NICE and specialty guidance on benzodiazepine prescribing duration and on withdrawal management
• Literature on benzodiazepine tolerance, physical dependence and the distinction from addiction
• Guidance on gradual dose reduction, including substitution with a longer-acting agent
• Beers criteria on potentially inappropriate medication use in older adults
• Studies of benzodiazepines, falls and fracture risk in older people
• Observational research on long-term benzodiazepine use and dementia risk
• Evidence on benzodiazepine-related driving impairment
• Trials of buspirone, SSRIs and cognitive behavioural therapy in generalised anxiety disorder
• Related reading: generalised anxiety disorder, stress and what helps
• Related products: anti-anxiety category
• RXshop Editorial Team — reviewed by Thomas Walsh, MD, Psychiatrist and Mental Health Specialist